{"id":27464,"date":"2026-11-20T06:30:02","date_gmt":"2026-11-20T06:30:02","guid":{"rendered":"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/"},"modified":"2026-11-20T06:31:00","modified_gmt":"2026-11-20T06:31:00","slug":"medibank-private-pestel-analysis-2026","status":"publish","type":"post","link":"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/","title":{"rendered":"Medibank Private PESTEL Analysis in 2026"},"content":{"rendered":"<p>Medibank Private Limited (ASX: MPL) is an Australian health insurer and healthcare services provider. This PESTEL Analysis analysis uses the company&#8217;s FY2025 Annual Report for all reported financial information. Figures are in Australian dollars.<\/p>\n<h2>Political Factors<\/h2>\n<h3>1. Premium policy and approvals<\/h3>\n<p>Australian government decisions on private health insurance premiums influence pricing flexibility and affordability. Medibank must manage claims costs while complying with the applicable approval process.<\/p>\n<h3>2. Public-private healthcare policy<\/h3>\n<p>Changes in public hospital capacity and government funding can influence private healthcare demand. The effects may differ across insurance and health services.<\/p>\n<h3>3. Health reform priorities<\/h3>\n<p>Policy encouraging prevention, homecare or integrated care may create opportunities for Amplar Health, but implementation and funding models matter.<\/p>\n<h3>4. Non-resident healthcare policy<\/h3>\n<p>Student and visitor visa arrangements can affect demand for non-resident insurance products. Changes in migration policy may alter customer volumes and mix.<\/p>\n<h3>5. Government scrutiny of insurers<\/h3>\n<p>Public debate about premiums, claims and value for money can influence regulation and customer trust. Transparent products and service standards are important.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a>.<\/p>\n<h2>Economic Factors<\/h2>\n<h3>1. Household cost-of-living pressure<\/h3>\n<p>Consumers may downgrade or switch cover when budgets tighten. Medibank must balance competitive premiums with sustainable claims funding.<\/p>\n<h3>2. Medical inflation<\/h3>\n<p>Hospital and treatment costs can rise faster than general inflation. Underwriting profitability depends on benefit design, utilisation and pricing.<\/p>\n<h3>3. Investment market returns<\/h3>\n<p>Medibank earned A$207.8 million in net investment income in FY2025. Financial market changes can affect statutory profit independently of insurance operations.<\/p>\n<h3>4. Wage and service cost inflation<\/h3>\n<p>Clinical and administrative labour costs influence both insurance expenses and health services margins. Productivity improvements can partly offset these pressures.<\/p>\n<h3>5. Customer acquisition economics<\/h3>\n<p>Marketing, commissions and switching behaviour determine the cost of attracting policyholders. Growth is less valuable when retention is weak.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a>.<\/p>\n<h2>Social Factors<\/h2>\n<h3>1. Ageing and health needs<\/h3>\n<p>Changing demographics can influence demand for healthcare and the claims mix. Risk equalisation and product design affect the insurance response.<\/p>\n<h3>2. Expectations of affordability<\/h3>\n<p>Customers increasingly scrutinise premiums, exclusions and perceived value. Clear communication can support informed product choices.<\/p>\n<h3>3. Preference for convenient care<\/h3>\n<p>Virtual, primary and home-based services may appeal to patients when clinically appropriate. Adoption depends on access and trust.<\/p>\n<h3>4. Preventative health engagement<\/h3>\n<p>Live Better and wellbeing initiatives may strengthen participation, although health and financial benefits require evidence.<\/p>\n<h3>5. Trust after data incidents<\/h3>\n<p>Sensitive health information makes privacy central to customer relationships. Past cybercrime costs reinforce the need for credible remediation and resilience.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a>.<\/p>\n<h2>Technological Factors<\/h2>\n<h3>1. Digital claims processing<\/h3>\n<p>Automation can improve speed and consistency, but decisions must remain accurate, reviewable and accessible to customers.<\/p>\n<h3>2. Virtual care platforms<\/h3>\n<p>Technology can extend access to clinicians and support home-based services. Clinical governance and continuity of care remain essential.<\/p>\n<h3>3. Cybersecurity controls<\/h3>\n<p>Insurance and healthcare systems hold sensitive information. Security investment must cover access, vendors, incident response and monitoring.<\/p>\n<h3>4. Data analytics for service<\/h3>\n<p>Analytics can improve demand forecasting and customer support when used responsibly. Privacy and fairness constraints limit inappropriate uses.<\/p>\n<h3>5. Integration of acquired systems<\/h3>\n<p>Growing health services can create fragmented technology environments. Interoperability is important for safe and efficient operations.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a>.<\/p>\n<h2>Environmental Factors<\/h2>\n<h3>1. Climate-related health impacts<\/h3>\n<p>Extreme heat, smoke and weather events may affect healthcare demand and service continuity. Impacts vary by geography and population.<\/p>\n<h3>2. Healthcare facility footprint<\/h3>\n<p>Clinics and care facilities consume energy and resources. Efficient operations can reduce environmental costs without compromising patient safety.<\/p>\n<h3>3. Operational resilience<\/h3>\n<p>Floods, fires and severe weather can interrupt facilities and staff access. Business continuity plans are essential.<\/p>\n<h3>4. Travel and care delivery<\/h3>\n<p>Appropriate virtual or home-based care may change travel patterns, though environmental benefits depend on actual service design.<\/p>\n<h3>5. Sustainability reporting<\/h3>\n<p>Stakeholders expect credible environmental disclosures. Claims about benefits should be supported by measured outcomes.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a>.<\/p>\n<h2>Legal Factors<\/h2>\n<h3>1. Private health insurance regulation<\/h3>\n<p>Product terms, premium processes and consumer obligations shape how Medibank sells and administers cover.<\/p>\n<h3>2. APRA prudential standards<\/h3>\n<p>Capital, risk management and governance requirements protect the insurer&#8217;s ability to meet policyholder obligations.<\/p>\n<h3>3. Privacy and data protection<\/h3>\n<p>Health information attracts significant legal and regulatory obligations. Breaches can lead to remediation and scrutiny.<\/p>\n<h3>4. Clinical licensing and standards<\/h3>\n<p>Healthcare services must meet applicable professional, facility and patient safety requirements across delivery settings.<\/p>\n<h3>5. Competition and consumer law<\/h3>\n<p>Marketing, exclusions, claims practices and acquisitions must comply with consumer protection and competition requirements.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\">Business Model<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a>.<\/p>\n<h3>The combined effect of policy and affordability<\/h3>\n<p>Government premium settings and private health insurance regulation shape the economic choices available to Medibank. Even when medical costs rise, the company cannot assume it can pass through all increases without affecting customer demand. Households compare cover against other spending priorities, and policy changes can alter incentives to maintain private insurance. Management should model regulation, claims inflation and customer switching together. A change that appears manageable in isolation may become material when several pressures occur at once.<\/p>\n<h3>Technology, privacy and clinical responsibility<\/h3>\n<p>Digital claims tools and virtual care can improve access and efficiency, but the risks differ. An incorrect insurance calculation may create financial harm or customer frustration; a clinical decision error can affect patient safety. Both systems handle sensitive data and require clear accountability. Medibank&#8217;s expansion into healthcare delivery increases the importance of professional oversight, reliable technology and privacy-by-design. Automation should be tested for accuracy, explainability and appropriate escalation rather than assessed solely by the number of manual tasks removed.<\/p>\n<h3>Economic cycles and investment income<\/h3>\n<p>Medibank&#8217;s insurance business earns premiums and pays claims, while its investment portfolio contributes a separate source of income. FY2025 net investment income was A$207.8 million. Market returns can fluctuate even when insurance operations remain resilient, which helps explain the distinction between statutory and underlying NPAT. Cost-of-living pressure may also influence policy retention and product mix. Investors should therefore distinguish market-driven earnings changes from underlying claims performance and customer growth.<\/p>\n<h3>Environmental effects on healthcare demand<\/h3>\n<p>Extreme heat, smoke and other climate-related events can influence health needs and disrupt facilities or staff availability. The financial effect on a health insurer is not necessarily immediate or uniform, because policies, risk equalisation and care pathways influence how costs emerge. Healthcare service operations also need continuity plans for severe weather. Medibank should assess physical risks across facilities, technology infrastructure and care delivery partners rather than relying only on broad environmental targets.<\/p>\n<h3>Regulatory capital and consumer protection<\/h3>\n<p>Insurance and healthcare activities operate under different but overlapping legal responsibilities. Prudential standards protect the insurer&#8217;s ability to meet claims, while consumer law and private health insurance rules govern product representations and customer treatment. Clinical standards apply to healthcare services, and privacy law governs sensitive information. A strategy that is commercially attractive but fails one of these obligations is not sustainable. Governance should integrate these requirements into product design, acquisitions, data systems and service delivery.<\/p>\n<h3>Why these factors cannot be analysed separately<\/h3>\n<p>The PESTEL categories are useful for organising external risks, but the real commercial effects are interconnected. For example, inflation can raise hospital costs and household living expenses simultaneously. Medibank may face higher claims while customers become less willing to accept premium increases. Government premium settings can constrain the speed of pricing adjustments. Technology investment may improve efficiency, yet also create new cybersecurity and privacy obligations. The strategic response requires integrated scenarios rather than separate forecasts for each category.<\/p>\n<h3>Practical indicators to monitor<\/h3>\n<p>Relevant indicators include resident policyholder growth and retention, claims utilisation, the insurance operating margin, management expenses, healthcare service profitability, complaints, cyber incidents and prudential capital. Policy announcements, wage growth and healthcare cost trends can help explain changes before they appear in annual profit. The FY2025 report&#8217;s distinction between statutory NPAT of A$500.8 million and underlying NPAT of A$618.7 million is a reminder to separate operating trends from investment and reserve effects. Management should update its external-risk assessment as evidence changes.<\/p>\n<h3>A responsible growth framework<\/h3>\n<p>The long-term objective is not simply to increase the number of insured members or healthcare facilities. Growth should be assessed against affordability, clinical quality, regulatory obligations and financial resilience. Expanding virtual and home-based care can create value when patients benefit and delivery economics are sustainable. New digital systems must preserve privacy and security. Premium decisions must account for expected claims and customer understanding. These principles connect the political, economic, social, technological, environmental and legal dimensions to measurable business outcomes.<\/p>\n<p><strong>Source:<\/strong> <a href=\"https:\/\/www.medibank.com.au\/content\/dam\/retail\/about-assets\/pdfs\/investor-centre\/annual-reports\/Medibank_AnnualReport2025.pdf\">Medibank FY2025 Annual Report<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medibank Private PESTEL Analysis in 2026: Medibank, ahm, Amplar Health, financial performance and healthcare risks based on the FY2025 Annual Report.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[156],"tags":[],"class_list":{"0":"post-27464","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-pestel-analysis"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Medibank Private PESTEL Analysis in 2026 - The Strategy Story<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medibank Private PESTEL Analysis in 2026 - The Strategy Story\" \/>\n<meta property=\"og:description\" content=\"Medibank Private PESTEL Analysis in 2026: Medibank, ahm, Amplar Health, financial performance and healthcare risks based on the FY2025 Annual Report.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"The Strategy Story\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-20T06:30:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-20T06:31:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/03\/TSS-logo-11-modified.png\" \/>\n\t<meta property=\"og:image:width\" content=\"403\" \/>\n\t<meta property=\"og:image:height\" content=\"403\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shikhar Goel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shikhar Goel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\",\"url\":\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\",\"name\":\"Medibank Private PESTEL Analysis in 2026 - The Strategy Story\",\"isPartOf\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\"},\"datePublished\":\"2026-11-20T06:30:02+00:00\",\"dateModified\":\"2026-11-20T06:31:00+00:00\",\"author\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071\"},\"breadcrumb\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thestrategystory.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medibank Private PESTEL Analysis in 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\",\"url\":\"https:\/\/thestrategystory.com\/blog\/\",\"name\":\"The Strategy Story\",\"description\":\"Simplifying Business Strategies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071\",\"name\":\"Shikhar Goel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g\",\"caption\":\"Shikhar Goel\"},\"url\":\"https:\/\/thestrategystory.com\/blog\/author\/tss-publisher\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medibank Private PESTEL Analysis in 2026 - The Strategy Story","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/","og_locale":"en_US","og_type":"article","og_title":"Medibank Private PESTEL Analysis in 2026 - The Strategy Story","og_description":"Medibank Private PESTEL Analysis in 2026: Medibank, ahm, Amplar Health, financial performance and healthcare risks based on the FY2025 Annual Report.","og_url":"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/","og_site_name":"The Strategy Story","article_published_time":"2026-11-20T06:30:02+00:00","article_modified_time":"2026-11-20T06:31:00+00:00","og_image":[{"width":403,"height":403,"url":"https:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/03\/TSS-logo-11-modified.png","type":"image\/png"}],"author":"Shikhar Goel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Shikhar Goel","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/","url":"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/","name":"Medibank Private PESTEL Analysis in 2026 - The Strategy Story","isPartOf":{"@id":"https:\/\/thestrategystory.com\/blog\/#website"},"datePublished":"2026-11-20T06:30:02+00:00","dateModified":"2026-11-20T06:31:00+00:00","author":{"@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071"},"breadcrumb":{"@id":"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thestrategystory.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Medibank Private PESTEL Analysis in 2026"}]},{"@type":"WebSite","@id":"https:\/\/thestrategystory.com\/blog\/#website","url":"https:\/\/thestrategystory.com\/blog\/","name":"The Strategy Story","description":"Simplifying Business Strategies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071","name":"Shikhar Goel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g","caption":"Shikhar Goel"},"url":"https:\/\/thestrategystory.com\/blog\/author\/tss-publisher\/"}]}},"_links":{"self":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/comments?post=27464"}],"version-history":[{"count":2,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27464\/revisions"}],"predecessor-version":[{"id":27470,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27464\/revisions\/27470"}],"wp:attachment":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/media?parent=27464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/categories?post=27464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/tags?post=27464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}